Primary |
Growth Hormone Deficiency |
15.2% |
Hypopituitarism |
12.1% |
Blood Corticotrophin Decreased |
7.8% |
Essential Hypertension |
6.2% |
Blood Follicle Stimulating Hormone Decreased |
5.4% |
Blood Thyroid Stimulating Hormone Decreased |
5.4% |
Primary Hypothyroidism |
5.2% |
Blood Luteinising Hormone Decreased |
4.7% |
Hypertension |
4.4% |
Product Used For Unknown Indication |
4.1% |
Diabetes Mellitus |
3.9% |
Major Depression |
3.6% |
Hypothyroidism |
3.4% |
Renal Failure Chronic |
3.4% |
Hypogonadism |
3.1% |
Epilepsy |
2.8% |
Hypogonadism Male |
2.8% |
Analgesic Therapy |
2.3% |
Prader-willi Syndrome |
2.3% |
Body Height Below Normal |
1.8% |
|
Death |
29.7% |
Anxiety |
4.7% |
Bone Sarcoma |
4.7% |
Craniopharyngioma |
4.7% |
Neoplasm Recurrence |
4.7% |
Pituitary Tumour Benign |
4.7% |
Sleep Apnoea Syndrome |
4.7% |
Somnolence |
4.7% |
Asthma |
3.1% |
Cerebrovascular Accident |
3.1% |
Circulatory Collapse |
3.1% |
Convulsion |
3.1% |
Drug Exposure During Pregnancy |
3.1% |
Dyspnoea |
3.1% |
Fall |
3.1% |
Headache |
3.1% |
Medulloblastoma Recurrent |
3.1% |
Melas Syndrome |
3.1% |
Nephrotic Syndrome |
3.1% |
Pneumonia |
3.1% |
|
Secondary |
Diabetes Mellitus |
15.9% |
Growth Hormone Deficiency |
15.2% |
Hypopituitarism |
9.8% |
Blood Corticotrophin Decreased |
6.8% |
Hiv Infection |
6.1% |
Product Used For Unknown Indication |
5.3% |
Secondary Adrenocortical Insufficiency |
5.3% |
Hypothyroidism |
4.5% |
Acquired Immunodeficiency Syndrome |
3.8% |
Hypogonadism |
3.8% |
Hormone Replacement Therapy |
3.0% |
Secondary Hypogonadism |
3.0% |
Small For Dates Baby |
3.0% |
Blood Thyroid Stimulating Hormone Decreased |
2.3% |
Constipation |
2.3% |
Diabetes Insipidus |
2.3% |
Prader-willi Syndrome |
2.3% |
Renal Transplant |
2.3% |
Blood Follicle Stimulating Hormone Decreased |
1.5% |
Blood Luteinising Hormone Decreased |
1.5% |
|
Myocardial Infarction |
13.7% |
Craniopharyngioma |
11.8% |
Melas Syndrome |
11.8% |
Sleep Apnoea Syndrome |
11.8% |
Brain Neoplasm |
7.8% |
Hepatoblastoma Recurrent |
5.9% |
Suicidal Ideation |
5.9% |
Germ Cell Cancer |
3.9% |
Melanocytic Naevus |
3.9% |
Muscle Hypertrophy |
3.9% |
Cerebral Haemorrhage |
2.0% |
Death |
2.0% |
Dizziness |
2.0% |
Hepatic Enzyme Increased |
2.0% |
Hyperlipidaemia |
2.0% |
Hypoglycaemia |
2.0% |
Hyponatraemia |
2.0% |
Nephrosclerosis |
2.0% |
Osteotomy |
2.0% |
Pituitary Tumour Benign |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
38.5% |
Juvenile Arthritis |
30.8% |
Renal Transplant |
7.7% |
Blood Growth Hormone |
3.8% |
Crohn's Disease |
3.8% |
Growth Retardation |
3.8% |
Precocious Puberty |
3.8% |
Prophylaxis |
3.8% |
Puberty |
3.8% |
|
Splenomegaly |
22.2% |
Asphyxia |
11.1% |
Astrocytoma |
11.1% |
Chronic Myelomonocytic Leukaemia |
11.1% |
Histiocytosis Haematophagic |
11.1% |
Hypotension |
11.1% |
Pyrexia |
11.1% |
Renal Failure |
11.1% |
|